An updated cost-effectiveness analysis of pneumococcal conjugate vaccine among children in Thailand

An updated cost-effectiveness analysis of pneumococcal conjugate vaccine among children in Thailand

© 2019 Elsevier Ltd Background: A previous cost-effectiveness analysis (CEA) showed that Pneumococcal Conjugate Vaccine (PCV) 10 and PCV13 were not cost-effective for universal immunization among children in Thailand. Given recent changes in the evidence of efficacy, herd effects and price, a CEA of...

Full description

Saved in:

Bibliographic Details
Main Authors:	Piyameth Dilokthornsakul, Kirati Kengkla, Surasak Saokaew, Unchalee Permsuwan, Chonnamet Techasaensiri, Tawee Chotpitayasunondh, Nathorn Chaiyakunapruk
Format:	Journal
Published:	2019
Subjects:	Biochemistry, Genetics and Molecular Biology Immunology and Microbiology Medicine Veterinary
Online Access:	https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85068260895&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/65357
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	Chiang Mai University

Similar Items

An updated cost-effectiveness analysis of pneumococcal conjugate vaccine among children in Thailand
by: Piyameth Dilokthornsakul, et al.
Published: (2020)

Cost-effectiveness of insulin detemir versus insulin glargine for Thai type 2 diabetes from a payer’s perspective
by: Unchalee Permsuwan, et al.
Published: (2018)

Cost-effectiveness of insulin detemir versus insulin glargine for Thai type 2 diabetes from a payer’s perspective
by: Unchalee Permsuwan, et al.
Published: (2018)

Long-Term Cost-Effectiveness of Insulin Glargine Versus Neutral Protamine Hagedorn Insulin for Type 2 Diabetes in Thailand
by: Unchalee Permsuwan, et al.
Published: (2018)

Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy versus sulfonylurea monotherapy for people with type 2 diabetes and chronic kidney disease in Thailand
by: Unchalee Permsuwan, et al.
Published: (2018)

Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy versus sulfonylurea monotherapy for people with type 2 diabetes and chronic kidney disease in Thailand
by: Unchalee Permsuwan, et al.
Published: (2018)

Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy in elderly type 2 diabetes patients in Thailand
by: Unchalee Permsuwan, et al.
Published: (2018)

Effect and cost-effectiveness of pneumococcal conjugate vaccination: a global modelling analysis
by: Chen, C., et al.
Published: (2022)

A cost-effectiveness analysis of the 13-valent pneumococcal conjugated vaccine and the 23-valent pneumococcal polysaccharide vaccine among Thai older adult
by: Ngamprasertchai T.
Published: (2023)

Pneumococcal infection among children before introduction of 13-valent pneumococcal conjugate vaccine, Cambodia
by: Paul Turner, et al.
Published: (2018)

Molecular epidemiology of pneumococcal colonization in response to pneumococcal conjugate vaccination in children with recurrent acute otitis media
by: Bogaert, D, et al.
Published: (2020)

Cost-effectiveness of pharmacist-participated warfarin therapy management in Thailand
by: Surasak Saokaew, et al.
Published: (2018)

Cost-effectiveness of pharmacist-participated warfarin therapy management in Thailand
by: Surasak Saokaew, et al.
Published: (2018)

Cost-effectiveness of pharmacist-participated warfarin therapy management in Thailand
by: Surasak Saokaew, et al.
Published: (2018)

Characterization of hypersensitivity reactions reported among Andrographis paniculata users in Thailand using Health Product Vigilance Center (HPVC) database
by: Wimon Suwankesawong, et al.
Published: (2018)

Safety of herbal products in Thailand: An analysis of reports in the thai health product vigilance center database from 2000 to 2008
by: Surasak Saokaew, et al.
Published: (2018)

Characterization of hypersensitivity reactions reported among Andrographis paniculata users in Thailand using Health Product Vigilance Center (HPVC) database
by: Wimon Suwankesawong, et al.
Published: (2018)

Pneumococcal colonization and severity of pneumonia in hospitalized Cambodian children following introduction of the 13-valent pneumococcal conjugate vaccine
by: Miliya T.
Published: (2023)

Pneumococcal nasopharyngeal carriage following reduced doses of a 7-valent pneumococcal conjugate vaccine and a 23-valent pneumococcal polysaccharide vaccine booster
by: Russell, F.M., et al.
Published: (2014)

Pneumococcal disease in Thailand
by: Amgad Gamil, et al.
Published: (2022)

Adult invasive pneumococcal disease pre- and peri-pneumococcal conjugate vaccine introduction in a tertiary hospital in Singapore
by: Hsu, L.-Y., et al.
Published: (2015)

Parental knowledge, attitudes and perception of pneumococcal disease and pneumococcal conjugate vaccines in Singapore: A questionnaire-based assessment
by: How, C.H, et al.
Published: (2020)

Cost-utility analysis of 10- and 13-valent pneumococcal conjugate vaccines: Protection at what price in the Thai context?
by: Wantanee Kulpeng, et al.
Published: (2018)

Cost-utility analysis of 10- and 13-valent pneumococcal conjugate vaccines: protection at what price in the Thai context?
by: Wantanee Kulpenga, et al.
Published: (2014)

Kawasaki disease following administration of 13-valent pneumococcal conjugate vaccine in young children
by: Yung, Chee Fu, et al.
Published: (2020)

Impact of 13-Valent Pneumococcal Conjugate Vaccine on Colonization and Invasive Disease in Cambodian Children
by: Paul Turner, et al.
Published: (2020)

The immunogenicity and safety of pneumococcal conjugate vaccine in human immunodeficiency virus-infected Thai children
by: Chareeya Thanee, et al.
Published: (2018)

Kawasaki Disease following administration of 13-valent pneumococcal conjugate vaccine in young children
by: Yung, C.F., et al.
Published: (2021)

Pneumococcal vaccine
by: V. Thamlikitkul
Published: (2018)

Anticoagulation control of pharmacist-managed collaborative care versus usual care in Thailand
by: Surasak Saokaew, et al.
Published: (2018)

Anticoagulation control of pharmacist-managed collaborative care versus usual care in Thailand
by: Surasak Saokaew, et al.
Published: (2018)

Serotype-Specific Changes in Invasive Pneumococcal Disease after Pneumococcal Conjugate Vaccine Introduction: A Pooled Analysis of Multiple Surveillance Sites
by: Daniel R. Feikin, et al.
Published: (2018)

A phase 3 study of safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine, in children with HIV
by: Wilck M.
Published: (2023)

Serotype-Specific Changes in Invasive Pneumococcal Disease after Pneumococcal Conjugate Vaccine Introduction: A Pooled Analysis of Multiple Surveillance Sites
by: Feikin D.R., et al.
Published: (2019)

Cost-effectiveness analysis of pharmacogenetic-guided warfarin dosing in Thailand
by: Huey Yi Chong, et al.
Published: (2018)

Immunogenicity following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine
by: Russell, F.M., et al.
Published: (2014)

Safety and immunogenicity of the 23-valent pneumococcal polysaccharide vaccine at 12 months of age, following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine in infancy
by: Russell, F.M., et al.
Published: (2014)

Weight Reduction and Pioglitazone are Cost-Effective for the Treatment of Non-Alcoholic Fatty Liver Disease in Thailand
by: Bunchai Chongmelaxme, et al.
Published: (2020)

Pneumococcal Vaccination in Children: A Systematic Review and Meta-Analysis of Cost-Effectiveness Studies
by: Syeed M.S.
Published: (2023)

Opsonophagocytic activity following a reduced dose 7-valent pneumococcal conjugate vaccine infant primary series and 23-valent pneumococcal polysaccharide vaccine at 12 months of age
by: Russell, F.M., et al.
Published: (2014)